SCHEMBL9897412

SCHEMBL9897412

COc1cc(-c2ncnc3c(C(=O)N[C@H]4CC[C@H](NC(C)=O)CC4)c(C)[nH]c23)c(OCC2CC2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 7/20 0.38
CDK9 P50750 4/20 0.37
CASP3 P42574 1/20 0.37
CASP7 P55210 1/20 0.37
CDK1 P06493 3/20 0.36
CDK2 P24941 3/20 0.36
RBP4 P02753 1/20 0.34
TTR P02766 1/20 0.34
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
PDE4B Q07343 2/20 0.33
CDK3 Q00526 2/20 0.33
CDK5 Q00535 2/20 0.33
PDE4D Q08499 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
CCNT1 O60563 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNE1 P24864 1/20 0.33
CCNA1 P78396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9897173 1.00 LRRK2 (0.38) LRRK2CDK9CASP3CASP7CDK1
SCHEMBL9897171 1.00 LRRK2 (0.38) LRRK2CDK9CASP3CASP7CDK1
SCHEMBL9897203 0.97 LRRK2 (0.38) LRRK2CDK9CASP3CASP7CDK1
SCHEMBL9897206 0.97 LRRK2 (0.38) LRRK2CDK9CASP3CASP7CDK1
SCHEMBL9898636 0.97 LRRK2 (0.38) LRRK2CDK9CASP3CASP7CDK1
SCHEMBL9896252 0.94 FFAR4 (0.34) LRRK2CDK9CASP3CASP7RBP4
SCHEMBL9896326 0.94 FFAR4 (0.34) LRRK2CDK9CASP3CASP7RBP4
SCHEMBL9896256 0.94 FFAR4 (0.34) LRRK2CDK9CASP3CASP7RBP4
SCHEMBL9897048 0.93 GRIN1 (0.35) LRRK2RBP4TTRPDE4BPDE4D
SCHEMBL9896227 0.93 GRIN1 (0.35) LRRK2RBP4TTRPDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US claimed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US claimed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP claimed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US claimed
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A LRRK2 3089/4885CDK9 641/4885CASP3 1037/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A LRRK2 3122/4885CDK9 808/4885CASP3 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.